For example, clinicians often draw blood in patients with prostate tumors, for assessing the prostate-specific antigen (PSA) for diagnosing early prostate cancer, but elevated PSA levels may be caused by multiple factors, which may result in overdiagnosis and over-treatment (13–16). This evidence concerns the gene KLK3 and prostate cancer.